Ziprasidone on SilverScript Choice (S5601-042)
Covered.
Tier 3 (preferred brand). Quantity limit of 60 per 30 days.
$9.02
Patient pays / month, after deductible
$47.46
Patient pays / month, before the $615.00 deductible
$27.05
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
ZIPRASIDONE 20 mg Capsule at a preferred retail pharmacy, from the plan's negotiated price of $47.46 for a month. Other covered strengths are listed below.
All 5 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| ZIPRASIDONE 20 mg Capsule | 3 | $9.02 | 60 per 30 days |
| ZIPRASIDONE 40 mg Capsule | 3 | $9.11 | 60 per 30 days |
| ZIPRASIDONE 60 mg Capsule | 3 | $11.22 | 60 per 30 days |
| ZIPRASIDONE 80 mg Capsule | 3 | $13.10 | 60 per 30 days |
| ZIPRASIDONE MESYLATE 20 mg/mL Injection, Powder, Lyophilized, For Solution | 4 | $452.06 | 6 per 3 days |
Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5601-042